Menicon Co (5FR) Price & Analysis
5FR Stock Chart & Stats
- Day’s Range
- EUR 10.00 - EUR 10.00
- 52-Week Range
- EUR 6.50 - EUR 10.90
- Previous Close
- EUR 9.95
- Volume
- 0
- Average Volume (3M)
- 4
- Market Cap
- EUR 794.25M
- Enterprise Value
- EUR 171.31B
- Total Cash (Recent Filing)
- EUR 34.07B
- Total Debt (Recent Filing)
- EUR 81.55B
- Price to Earnings (P/E)
- 19.1
- Beta
- 0.42
- Next Earnings
- Nov 13, 2026
- EPS Estimate
- 0.14
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 1.46%
Bulls Say, Bears Say
Bulls Say
Steady Revenue Growth
The sustained increase in revenue indicates expanding commercial activity across Menicon’s vision-care portfolio. Although growth has slowed recently, the multi-year trajectory supports a durable base of demand and provides scale that can help fund continued product development and market expansion.
Strong Gross Economics
A consistently high gross margin shows that Menicon retains meaningful economics after direct product costs. This provides a buffer against operating pressure, supports reinvestment in contact lenses and eye-care products, and gives the company a foundation to rebuild profitability if below-the-line pressures ease.
Growing Equity Base
The expanding equity base strengthens Menicon’s balance-sheet foundation and provides a larger capital cushion for ongoing operations and investment. This accumulated capital can improve resilience over the medium term, even though rising debt means the benefit is partly offset by greater leverage.
Bears Say
Weak Free Cash Flow
Recurring negative free cash flow means accounting profitability is not consistently translating into cash available for debt reduction, dividends, or discretionary investment. Continued cash consumption could reduce financial flexibility and make Menicon more dependent on efficient investment execution and external funding.
Rising Leverage And Lower ROE
Higher debt relative to equity reduces room to absorb operational setbacks and constrains future capital allocation flexibility. At the same time, declining ROE indicates that the larger capital base is currently being used less efficiently, weakening the quality of recent balance-sheet growth.
Profitability Compression
Stable gross margins have not prevented operating and net profitability from falling from prior peaks. The combination of slower recent revenue growth and lower net margin could limit earnings expansion, reduce internal funding capacity, and make future performance more sensitive to operating-cost control.
Menicon Co News
5FR FAQ
What was Menicon Co’s price range in the past 12 months?
What is Menicon Co’s market cap?
When is Menicon Co’s upcoming earnings report date?
How were Menicon Co’s earnings last quarter?
Is Menicon Co overvalued?
Does Menicon Co pay dividends?
What is Menicon Co’s EPS estimate?
How many shares outstanding does Menicon Co have?
What happened to Menicon Co’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Menicon Co?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Menicon Co
Menicon Co., Ltd. is a company dedicated to the manufacturing and global distribution of contact lenses and their essential care solutions. The firm supplies its range of eye care products to a diverse network of outlets, including medical facilities like hospitals and ophthalmology clinics, as well as retail channels such as specialized contact lens stores, eyewear retailers, and pharmacies. With a substantial international presence, Menicon extends its reach to over 80 countries, encompassing major markets in the United States, Europe, Oceania, and Asia. This Japanese entity, which was founded in 1943, is based in Nagoya.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Koji Kawaura
- Employees
- 4,493
- Website
- www.menicon.co.jp
- Address
- 3-21-19, Aoi, Nagoya, AI, 460-0006, JP
Menicon Co (5FR) Earnings & Revenues
5FR Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 11 | 3 | 8 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 6 | 0 | 6 |









